These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 312991)

  • 1. Antirheumatic therapy.
    Potter S
    Med J Aust; 1979 Apr; 1(S2):19-21. PubMed ID: 312991
    [No Abstract]   [Full Text] [Related]  

  • 2. Disease-modifying antirheumatic drugs: gold, penicillamine, antimalarials, and sulfasalazine.
    Smith MD
    Curr Opin Rheumatol; 1990 Jun; 2(3):489-96. PubMed ID: 1975503
    [No Abstract]   [Full Text] [Related]  

  • 3. [Problems of basic therapy of rheumatic diseases with chloroquine, gold and D-penicillamine].
    Meyer W; Weyerbrock W
    Internist (Berl); 1979 Sep; 20(9):426-32. PubMed ID: 115810
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-rheumatic drugs.
    Littler TR
    Pharmacol Ther; 1981; 15(1):45-68. PubMed ID: 6121334
    [No Abstract]   [Full Text] [Related]  

  • 5. Arthritis and rheumatism: old questions, new answers.
    Roth SH
    Compr Ther; 1984 Aug; 10(8):58-64. PubMed ID: 6331979
    [No Abstract]   [Full Text] [Related]  

  • 6. Disease-modifying antirheumatic drugs: gold, penicillamine, antimalarials, and sulfasalazine.
    Smith MD
    Curr Opin Rheumatol; 1989 Jun; 1(1):74-9. PubMed ID: 2577111
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dosage and adverse effects of commonly used antirheumatic agents].
    Mathies H
    Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):320-6. PubMed ID: 5317064
    [No Abstract]   [Full Text] [Related]  

  • 8. Rheumatoid arthritis therapy: the slow-acting agents.
    Hardin JG
    Hosp Pract (Off Ed); 1989 Jun; 24(6):163-8, 170, 173-8. PubMed ID: 2566617
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclophosphamide, gold and penicillamine--disease-modifying drugs in rheumatoid arthritis--tailored dosage and ultimate success.
    Gumpel JM
    Rheumatol Rehabil; 1976 Aug; 15(3):217-20. PubMed ID: 968355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is penicillamine therapy in rheumatoid arthritis influenced by previous treatment with gold?
    Webley M; Coomes EN
    Br Med J; 1978 Jul; 2(6130):91. PubMed ID: 667575
    [No Abstract]   [Full Text] [Related]  

  • 11. Disease-modifying antirheumatic drugs, including methotrexate, sulfasalazine, gold, antimalarials, and penicillamine.
    Girgis L; Conaghan PG; Brooks P
    Curr Opin Rheumatol; 1994 May; 6(3):252-61. PubMed ID: 7914739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease-modifying antirheumatic drugs, including methotrexate, sulfasalazine, gold, antimalarials, and D-penicillamine.
    Conaghan PG; Brooks P
    Curr Opin Rheumatol; 1993 May; 5(3):276-81. PubMed ID: 8099805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of toxic or therapeutic interaction between penicillamine and previously administered gold in a trial of penicillamine in rheumatoid disease.
    Postgrad Med J; 1974 Aug; 50 Suppl 2():77-8. PubMed ID: 4619474
    [No Abstract]   [Full Text] [Related]  

  • 14. [Long-term drug therapy in inflammatory rheumatic diseases using chronic polyarthritis as an example. 2. Basic principles of long-term drug therapy: choice of optimal therapeutic agents].
    Menninger H; Burkhardt H
    Fortschr Med; 1983 Apr; 101(14):639-45. PubMed ID: 6406333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical treatment of chronic inflammatory rheumatic diseases.
    Kahn MF
    Scand J Rheumatol Suppl; 1975; 12():97-104. PubMed ID: 1084573
    [No Abstract]   [Full Text] [Related]  

  • 16. Are slow-acting antirheumatic drugs being given earlier in rheumatoid arthritis?
    Spector TD; Thompson PW; Evans SJ; Scott PL
    Br J Rheumatol; 1988 Dec; 27(6):498-9. PubMed ID: 2904831
    [No Abstract]   [Full Text] [Related]  

  • 17. Antirheumatic agents.
    Evens RP
    J Maine Med Assoc; 1979 Apr; 70(4):154-67. PubMed ID: 312309
    [No Abstract]   [Full Text] [Related]  

  • 18. [Basic therapy of rheumatic diseases].
    Trnavskiĭ K
    Vopr Revm; 1981; (3):69-70. PubMed ID: 7032069
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent developments in disease-modifying antirheumatic drugs.
    Hunneyball IM
    Prog Drug Res; 1980; 24():101-216. PubMed ID: 7005959
    [No Abstract]   [Full Text] [Related]  

  • 20. Disease-modifying antirheumatic drugs.
    Stecher VJ; Carlson JA; Connolly KM; Bailey DM
    Med Res Rev; 1985; 5(3):371-90. PubMed ID: 3894835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.